Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760799 · ClinicalTrials.gov registry record · Phase 4
Randomized Study of Anular Repair With the Xclose Tissue Repair System
A Phase 4 study of Diskectomy, sponsored by Anulex Technologies.
- Completed
- Registry status
- Phase 4
- Development phase
- 750
- Enrollment target
- 20
- Study locations
NCT00760799 is a Phase 4 study of Diskectomy that has completed, run by Anulex Technologies. The registered enrollment target is 750 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT00760799, a Phase 4 study of Diskectomy, has completed, sponsored by Anulex Technologies.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 750 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the benefits of anulus fibrosus repair utilizing Xclose™ compared to a discectomy without anulus fibrosus repair.
Conditions Studied
Interventions
- PROCEDURE Discectomy with anular repair
Study Locations (20)
Florida
- North Florida Regional Hospital - Gainesville
- Lyerly Neurosurgical (Baptist Health) - Jacksonville
- Mayo Clinic - Jacksonville
- Lyerly Neurosurgical (Centerone) - Jacksonville
Illinois
- Midwest Orthopaedics at Rush - Chicago
- Chicago Institute of Neurosurgery and Neuroresearch - Chicago
- Palos Community Hospital - Palos Heights
Arizona
- Texas Back Institute - Phoenix
- Desert Institute for Spine Care - Phoenix
Colorado
- Denver Spine (Porter Hospital) - Greenwood Village
- Denver Spine (Presbyterian/St. Luke's Hospital) - Greenwood Village
Michigan
- Oakwood Hospital - Dearborn
- Henry Ford - Detroit
Alabama
- North Alabama Neurological, P.A. - Huntsville
California
- University of California San Diego - San Diego
Indiana
- Indiana Spine Group - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00760799
The ClinicalTrials.gov registry entry for NCT00760799 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anulex Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diskectomy appearing as the primary indexed condition, and to 1 intervention - of which Discectomy with anular repair is the first listed.
NCT00760799 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Illinois, Arizona.
Frequently Asked Questions
What is clinical trial NCT00760799 about?
NCT00760799 is a clinical study titled "Randomized Study of Anular Repair With the Xclose Tissue Repair System". The purpose of this study is to evaluate the benefits of anulus fibrosus repair utilizing Xclose™ compared to a discectomy without anulus fibrosus repair.
What is the current status of trial NCT00760799?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 750 participants. The study started on 2007-03. Estimated completion is 2012-01.
What conditions does trial NCT00760799 study?
This clinical trial studies the following conditions: Diskectomy.
What interventions are being tested in trial NCT00760799?
The interventions under investigation include: Discectomy with anular repair (PROCEDURE).
Who is sponsoring clinical trial NCT00760799?
This trial is sponsored by Anulex Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00760799 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diskectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.